-
article
Bruxelles Q, Hamel-Côté G, Scott-Boyer MP, Ouellette V, C-Gaudreault R, Durocher F, Diorio C, Droit A, Fortin S
FOXA1 and RAB25 as Biomarkers of Breast Cancer Cell Response to CYP1A1-Activated Prodrugs: Insights from CEU-938
Pharmaceuticals (Basel)
19 (3), 2026.
-
article
Sahli A, C-Gaudreault R, Marceau F
Non-peptide bradykinin B2 receptor ligands possessing the substituted quinolinyl moiety: pharmacological properties and prospective clinical uses
Peptides
195 2026.
-
article
Chavez Alvarez AC, Bouzriba C, Ouellette V, Gagné-Boulet M, Patenaude A, Pilote S, C-Gaudreault R, Simard C, Fortin S
Toxicity, Half-Life and Antitumor Activity of Phenyl 4-(2-Oxo-3-alkylimidazolidin-1-yl)benzenesulfonates as Novel Antimitotic CYP1A1-Targeted Prodrugs in Female Mouse Models
Pharmaceutics
17 (2), 2025.
